M. Farbstein

595 total citations
10 papers, 412 citations indexed

About

M. Farbstein is a scholar working on Oncology, Physiology and Molecular Biology. According to data from OpenAlex, M. Farbstein has authored 10 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in M. Farbstein's work include Adenosine and Purinergic Signaling (4 papers), Peptidase Inhibition and Analysis (4 papers) and Click Chemistry and Applications (1 paper). M. Farbstein is often cited by papers focused on Adenosine and Purinergic Signaling (4 papers), Peptidase Inhibition and Analysis (4 papers) and Click Chemistry and Applications (1 paper). M. Farbstein collaborates with scholars based in Israel, Bulgaria and Canada. M. Farbstein's co-authors include Flora Lubin, Itzik Klein, Aharon Hallak, Tuvia Gilat, Shimon Reif, Hanan Farbstein, B Arieli, Leon Bat, Paul Rozen and Esther Alfandary and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Journal of Hepatology.

In The Last Decade

M. Farbstein

10 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Farbstein Israel	5	196	134	101	69	67	10	412
Lorena Pirola Italy	7	126 0.6×	94 0.7×	66 0.7×	43 0.6×	43 0.6×	10	286
Armin Raible Germany	10	82 0.4×	94 0.7×	55 0.5×	45 0.7×	31 0.5×	22	375
M Huorka Slovakia	11	170 0.9×	194 1.4×	141 1.4×	69 1.0×	90 1.3×	34	433
L. Monetini Italy	9	150 0.8×	61 0.5×	108 1.1×	67 1.0×	28 0.4×	16	313
W Kruis Germany	6	168 0.9×	129 1.0×	117 1.2×	57 0.8×	56 0.8×	18	343
Ángel Ponferrada Spain	9	160 0.8×	129 1.0×	117 1.2×	54 0.8×	29 0.4×	22	355
Ana Cabanne Argentina	11	118 0.6×	195 1.5×	208 2.1×	51 0.7×	85 1.3×	28	486
Elizabeth E. Mannick United States	11	117 0.6×	112 0.8×	76 0.8×	71 1.0×	14 0.2×	18	402
L D Juby United Kingdom	8	133 0.7×	167 1.2×	113 1.1×	38 0.6×	32 0.5×	12	364

Countries citing papers authored by M. Farbstein

Since Specialization

Citations

This map shows the geographic impact of M. Farbstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Farbstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Farbstein more than expected).

Fields of papers citing papers by M. Farbstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Farbstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Farbstein. The network helps show where M. Farbstein may publish in the future.

Co-authorship network of co-authors of M. Farbstein

This figure shows the co-authorship network connecting the top 25 collaborators of M. Farbstein. A scholar is included among the top collaborators of M. Farbstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Farbstein. M. Farbstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Papp, Kim, Tomasz Blicharski, Avital Bareket‐Samish, et al.. (2024). Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1). Journal of the European Academy of Dermatology and Venereology. 38(6). 1112–1120. 18 indexed citations

Cohen, Shira, et al.. (2015). THU0064 The A3 Adenosine Receptor (A3AR): Therapeutic Target and Predictive Biological Marker in Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 215–215. 2 indexed citations

Stemmer, Salomon M., Ofer Benjaminov, Michael H. Silverman, et al.. (2012). 1411 CF102 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION STUDY. Journal of Hepatology. 56. S555–S555. 4 indexed citations

Stemmer, Salomon M., et al.. (2010). 384 Phase 1/2 trial of CF102, a selective A3 adenosine receptor (A3AR) agonist, in patients with hepatocellular carcinoma (HCC). European Journal of Cancer Supplements. 8(7). 122–122. 1 indexed citations

Stemmer, Salomon M., Adi Shani, Michael H. Silverman, et al.. (2006). A phase II, multi-center study of a new non-cytotoxic A₃ adenosine receptor agonist CF101, dose-finding (randomized blinded) in patients (pts) with refractory metastatic colorectal cancer. Journal of Clinical Oncology. 24(18_suppl). 13082–13082. 4 indexed citations

Stemmer, Salomon M., et al.. (2004). A phase II, multi-center study of a new non-cytotoxic A3 adenosine receptor agonist CF101, dose-finding (randomized blinded) in patients (pts)with refractory metastatic colorectal cancer. Journal of Clinical Oncology. 22(14_suppl). 3153–3153. 2 indexed citations

Lubin, Flora, Hanan Farbstein, Angela Chetrit, et al.. (2000). The role of nutritional habits during gestation and child life in pediatric brain tumor etiology. International Journal of Cancer. 86(1). 139–143. 30 indexed citations

Reif, Shimon, Itzik Klein, Flora Lubin, et al.. (1997). Pre-illness dietary factors in inflammatory bowel disease.. Gut. 40(6). 754–760. 249 indexed citations

Lubin, Flora, Paul Rozen, B Arieli, et al.. (1997). Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology.. PubMed. 6(2). 79–85. 77 indexed citations

10.

Farbstein, M., et al.. (1980). Use of right atrial catheter for prolonged iv support in cancer patients.. PubMed. 64(2-3). 243–6. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact